Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-007514
Filing Date
2025-09-25
Accepted
2025-09-25 16:19:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5443
  Complete submission text file 0001950047-25-007514.txt   6854
Mailing Address 802 NORTH DOUTY STREET HANFORD CA 93230
Business Address
Szot Matthew K (Reporting) CIK: 0001401385 (see all company filings)

Type: 144

Mailing Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Subject) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41596 | Film No.: 251344005
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)